Artigo Acesso aberto Revisado por pares

Assessment of thirty‐day readmission rate, timing, causes and predictors after hospitalization with COVID‐19

2021; Wiley; Volume: 290; Issue: 1 Linguagem: Inglês

10.1111/joim.13241

ISSN

1365-2796

Autores

Ilhwan Yeo, Sun Young Baek, Ji Hoon Kim, Hadya Elshakh, A. Voronina, Manxue Lou, Joshua Vapnik, Ravinder Kaler, Xuming Dai, Seth Goldbarg,

Tópico(s)

Long-Term Effects of COVID-19

Resumo

Abstract Background There are limited data on the characteristics of 30‐day readmission after hospitalization with coronavirus disease 2019 (COVID‐19). Objectives To examine the rate, timing, causes, predictors and outcomes of 30‐day readmission after COVID‐19 hospitalization. Methods From 13 March to 9 April 2020, all patients hospitalized with COVID‐19 and discharged alive were included in this retrospective observational study. Multivariable logistic regression was used to identify the predictors of 30‐day readmission, and a restricted cubic spline function was utilized to assess the linearity of the association between continuous predictors and 30‐day readmission. Results A total of 1062 patients were included in the analysis, with a median follow‐up time of 62 days. The mean age of patients was 56.5 years, and 40.5% were women. At the end of the study, a total of 48 (4.5%) patients were readmitted within 30 days of discharge, and a median time to readmission was 5 days. The most common primary diagnosis of 30‐day readmission was a hypoxic respiratory failure (68.8%) followed by thromboembolism (12.5%) and sepsis (6.3%). The patients with a peak serum creatinine level of ≥1.29 mg/dL during the index hospitalization, compared to those with a creatinine of <1.29 mg/dL, had 2.4 times increased risk of 30‐day readmission (adjusted odds ratio: 2.41; 95% CI: 1.23–4.74). The mortality rate during the readmission was 22.9%. Conclusion With 4.5% of the thirty‐day readmission rate, COVID‐19 survivors were readmitted early after hospital discharge, mainly due to morbidities of COVID‐19. One in five readmitted COVID‐19 survivors died during their readmission.

Referência(s)